Rovida Investment Management Ltd Makes New $990,000 Investment in ASP Isotopes Inc. (NASDAQ:ASPI)

Rovida Investment Management Ltd purchased a new position in ASP Isotopes Inc. (NASDAQ:ASPI - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 218,972 shares of the company's stock, valued at approximately $990,000. ASP Isotopes comprises approximately 0.3% of Rovida Investment Management Ltd's holdings, making the stock its 18th biggest position. Rovida Investment Management Ltd owned about 0.31% of ASP Isotopes as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of ASPI. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in shares of ASP Isotopes during the third quarter valued at approximately $6,249,000. Charles Schwab Investment Management Inc. grew its stake in ASP Isotopes by 16.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company's stock worth $334,000 after acquiring an additional 17,159 shares in the last quarter. The Manufacturers Life Insurance Company bought a new position in ASP Isotopes during the 3rd quarter worth about $52,000. Corsair Capital Management L.P. bought a new position in shares of ASP Isotopes during the third quarter valued at approximately $158,000. Finally, MetLife Investment Management LLC purchased a new position in shares of ASP Isotopes in the 3rd quarter valued at $88,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Stock Down 11.6 %

Shares of ASP Isotopes stock traded down $0.55 on Friday, reaching $4.18. The stock had a trading volume of 1,735,455 shares, compared to its average volume of 2,231,208. ASP Isotopes Inc. has a 1 year low of $1.86 and a 1 year high of $9.33. The company has a 50 day moving average price of $5.01 and a 200 day moving average price of $4.92. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $298.41 million, a P/E ratio of -6.85 and a beta of 3.66.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.